In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3: Acute Heart Failure
Session

Event : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 27 May 2019
  • Time : 10:30 - 20:00

20 presentations in this session

The efficacy of tolvaptan in acute heart failure - an updated meta-analysis

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : K Tanhui (Manila,PH)

Levosimendan alone or combined with inotropes in an acute heart failure unit

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : B Rocha (Lisbon,PT)

Effects of levosimendan in patients with chagas cardiomyopathy hospitalized for acute heart failure

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : GK Perez Cortes (Oaxaca De Juarez,MX)

A formula to calculate discharge furosemide dose after an acute heart failure hospitalization

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : P Bettencourt (Leca Palmeira,PT)

Development and validation of a Portuguese questionnaire to evaluate knowledge about heart failure

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : T Fidelis da Silva Foltran (Porto,PT)

Early reevaluation after acute heart failure: experience from a dedicated clinic

Event : Heart Failure 2019

  • Session : Acute Heart Failure
  • Speaker : GJ Lopes da Cunha (Lisboa,PT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are